English

CORMEDIX INC.

EDGAR

CRMD Current report (8-K) · filed 2026-10-19

Annual consolidated revenue for 2025: about USD 311.7M, using the latest reported figures. The previous period, 2024, was about USD 43.47M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

102 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 101931000 USD Source

Operating margin

42.1%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 42910000 USD Source
Revenue: 101931000 USD Source

Operating cash flow

86.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 128619000 USD Source
Operating Cash Flow: 42382000 USD Source

Free cash flow

85.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 128619000 USD Source
Operating Cash Flow: 42382000 USD Source
Capital Expenditure: 1290000 USD Source
Capital Expenditure: 729000 USD Source

Cash and cash equivalents: 257 million USD 2026-06-30 Source
Exact value

256692000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 77.7 million shares 2026-06-30 Source
Exact value

77667011 shares

Reported share-count change

4.08% · 3.05 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

74620742 shares · 2025-06-30· Source
77667011 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

462 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 104275289 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 311709000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 183093736 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 127427000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 101931000 USD · 2026-04-01 – 2026-06-30 Source

Net income

187 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: 108562980 USD · 2025-07-01 – 2025-09-30 Source
Net income: 163055000 USD · 2025-01-01 – 2025-12-31 Source
Net income: 149034859 USD · 2025-01-01 – 2025-09-30 Source
Net income: 38601000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 25988000 USD · 2026-04-01 – 2026-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-19.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 10 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+617%

Prior period

USD 43.47 million

2024-01-01 – 2024-12-31
Current period

USD 311.71 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

311709000 − 43472000 = 268237000 USD

43472000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
311709000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Year-over-year change in Revenue: 268237000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 311709000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#1331497 Filing: 000121390026023889 Input fundies:Revenue: 43472000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#1331915 Filing: 000121390026023889
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 180.99 million

Prior period

−USD 17.93 million

2024-01-01 – 2024-12-31
Current period

USD 163.06 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

163055000 − -17930000 = 180985000 USD

-17930000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
163055000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Year-over-year change in Net income: 180985000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 163055000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#1360520 Filing: 000121390026023889 Input fundies:NetIncome: -17930000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#935210 Filing: 000121390026023889
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 225.66 million

Prior period

−USD 50.62 million

2024-01-01 – 2024-12-31
Current period

USD 175.05 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

175046000 − -50615000 = 225661000 USD

-50615000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
175046000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Year-over-year change in Operating cash flow: 225661000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 175046000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#723435 Filing: 000121390026023889 Input fundies:OperatingCashFlow: -50615000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#723888 Filing: 000121390026023889
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+1,848.3%

Prior period

USD 116,000

2024-01-01 – 2024-12-31
Current period

USD 2.26 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

2260000 − 116000 = 2144000 USD

116000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
2260000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Year-over-year change in Capital expenditure: 2144000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2260000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#727877 Filing: 000121390026023889 Input fundies:CapitalExpenditure: 116000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#728323 Filing: 000121390026023889
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 311.71 million 100% of revenue
Cost of revenue USD 22.09 million 7.1% of revenue
Operating expenses USD 125.61 million 40% of revenue
Other operating costs Derived USD 13.87 million 4.5% of revenue
Operating income USD 150.14 million 48% of revenue
Tax, interest and other Derived −USD 12.91 million −4.1% of revenue
Net income USD 163.06 million 52% of revenue

Cash

Operating cash flow USD 175.05 million 56% of revenue
Capital expenditure USD 2.26 million 0.7% of revenue
Free cash flow Derived USD 172.79 million 55% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 11,149% of revenue.
2017 Operating loss: operating costs were 10,097% of revenue.
2018 Operating loss: operating costs were 6,350% of revenue.
2019 Operating loss: operating costs were 7,516% of revenue.
2020 Operating loss: operating costs were 11,478% of revenue.
2021 Operating loss: operating costs were 15,518% of revenue.
2022 Operating loss: operating costs were 46,920% of revenue.
2024 Operating loss: operating costs were 151% of revenue.
2025 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	224105	24985023 Derived	-24760918	-117291 Derived	-24643627	-22324118 Derived	Source 2016-01-01 – 2016-12-31: 224105 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -24760918 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -24643627 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -22265395 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 58723 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	329327	33253437 Derived	-32924110	85804 Derived	-33009914	-28739168 Derived	Source 2017-01-01 – 2017-12-31: 329327 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -32924110 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -33009914 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -28587180 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 151988 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	429797	27293993 Derived	-26864196	-34566 Derived	-26829630	-23749458 Derived	Source 2018-01-01 – 2018-12-31: 429797 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -26864196 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -26829630 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -23700565 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 48893 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	283266	21291142 Derived	-21007876	-4574802 Derived	-16433074	-15088595 Derived	Source 2019-01-01 – 2019-12-31: 283266 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -21007876 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -16433074 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -15052024 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 36571 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	239231	27459983 Derived	-27220752	-5193069 Derived	-22027683	-22080276 Derived	Source 2020-01-01 – 2020-12-31: 239231 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -27220752 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -22027683 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -21967638 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 112638 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	190936	29628521 Derived	-29437585	-1227359 Derived	-28210226	-22580552 Derived	Source 2021-01-01 – 2021-12-31: 190936 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -29437585 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -28210226 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -21155223 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1425329 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	65408	30689376 Derived	-30623968	-923968 Derived	-29700000	-24576092 Derived	Source 2022-01-01 – 2022-12-31: 65408 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -30623968 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -29700000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -24356732 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 219360 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	43472000	65828000 Derived	-22356000	-4426000 Derived	-17930000	-50731000 Derived	Source 2024-01-01 – 2024-12-31: 43472000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -22356000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -17930000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -50615000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 116000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	311709000	161568000 Derived	150141000	-12914000 Derived	163055000	172786000 Derived	Source 2025-01-01 – 2025-12-31: 311709000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 150141000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 163055000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 175046000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 2260000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 311.7M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	210130	Revenue: 210130 Open source
20162016-12-31	Revenue	224105	Revenue: 224105 Open source
20172017-12-31	Revenue	329327	Revenue: 329327 Open source
20182018-12-31	Revenue	429797	Revenue: 429797 Open source
20192019-12-31	Revenue	283266	Revenue: 283266 Open source
20202020-12-31	Revenue	239231	Revenue: 239231 Open source
20212021-12-31	Revenue	190936	Revenue: 190936 Open source
20222022-12-31	Revenue	65408	Revenue: 65408 Open source
20242024-12-31	Revenue	43472000	Revenue: 43472000 Open source
20252025-12-31	Revenue	311709000	Revenue: 311709000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

617% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 210130 Open source
20162016-12-31	Year over year	6.7%	Revenue: 224105 Open source Revenue: 210130 Open source
20172017-12-31	Year over year	47%	Revenue: 329327 Open source Revenue: 224105 Open source
20182018-12-31	Year over year	30.5%	Revenue: 429797 Open source Revenue: 329327 Open source
20192019-12-31	Year over year	-34.1%	Revenue: 283266 Open source Revenue: 429797 Open source
20202020-12-31	Year over year	-15.5%	Revenue: 239231 Open source Revenue: 283266 Open source
20212021-12-31	Year over year	-20.2%	Revenue: 190936 Open source Revenue: 239231 Open source
20222022-12-31	Year over year	-65.7%	Revenue: 65408 Open source Revenue: 190936 Open source
20242024-12-31	Year over year	No prior comparable period	Revenue: 43472000 Open source
20252025-12-31	Year over year	617%	Revenue: 311709000 Open source Revenue: 43472000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 48.2% 2025

Net margin 52.3% 2025

Free cash flow margin 55.4% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-7,925.6%	Operating Income: -16653971 Open source Revenue: 210130 Open source
20162016-12-31	Operating margin	-11,048.8%	Operating Income: -24760918 Open source Revenue: 224105 Open source
20172017-12-31	Operating margin	-9,997.4%	Operating Income: -32924110 Open source Revenue: 329327 Open source
20182018-12-31	Operating margin	-6,250.4%	Operating Income: -26864196 Open source Revenue: 429797 Open source
20192019-12-31	Operating margin	-7,416.3%	Operating Income: -21007876 Open source Revenue: 283266 Open source
20202020-12-31	Operating margin	-11,378.4%	Operating Income: -27220752 Open source Revenue: 239231 Open source
20212021-12-31	Operating margin	-15,417.5%	Operating Income: -29437585 Open source Revenue: 190936 Open source
20222022-12-31	Operating margin	-46,819.9%	Operating Income: -30623968 Open source Revenue: 65408 Open source
20242024-12-31	Operating margin	-51.4%	Operating Income: -22356000 Open source Revenue: 43472000 Open source
20252025-12-31	Operating margin	48.2%	Operating Income: 150141000 Open source Revenue: 311709000 Open source
20152015-12-31	Net margin	-8,655.4%	Net Income: -18187529 Open source Revenue: 210130 Open source
20162016-12-31	Net margin	-10,996.5%	Net Income: -24643627 Open source Revenue: 224105 Open source
20172017-12-31	Net margin	-10,023.4%	Net Income: -33009914 Open source Revenue: 329327 Open source
20182018-12-31	Net margin	-6,242.4%	Net Income: -26829630 Open source Revenue: 429797 Open source
20192019-12-31	Net margin	-5,801.3%	Net Income: -16433074 Open source Revenue: 283266 Open source
20202020-12-31	Net margin	-9,207.7%	Net Income: -22027683 Open source Revenue: 239231 Open source
20212021-12-31	Net margin	-14,774.7%	Net Income: -28210226 Open source Revenue: 190936 Open source
20222022-12-31	Net margin	-45,407.3%	Net Income: -29700000 Open source Revenue: 65408 Open source
20242024-12-31	Net margin	-41.2%	Net Income: -17930000 Open source Revenue: 43472000 Open source
20252025-12-31	Net margin	52.3%	Net Income: 163055000 Open source Revenue: 311709000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 210130 Open source
20162016-12-31	Free cash flow margin	-9,961.5%	Revenue: 224105 Open source Operating Cash Flow: -22265395 Open source Capital Expenditure: 58723 Open source
20172017-12-31	Free cash flow margin	-8,726.6%	Revenue: 329327 Open source Operating Cash Flow: -28587180 Open source Capital Expenditure: 151988 Open source
20182018-12-31	Free cash flow margin	-5,525.7%	Revenue: 429797 Open source Operating Cash Flow: -23700565 Open source Capital Expenditure: 48893 Open source
20192019-12-31	Free cash flow margin	-5,326.7%	Revenue: 283266 Open source Operating Cash Flow: -15052024 Open source Capital Expenditure: 36571 Open source
20202020-12-31	Free cash flow margin	-9,229.7%	Revenue: 239231 Open source Operating Cash Flow: -21967638 Open source Capital Expenditure: 112638 Open source
20212021-12-31	Free cash flow margin	-11,826.2%	Revenue: 190936 Open source Operating Cash Flow: -21155223 Open source Capital Expenditure: 1425329 Open source
20222022-12-31	Free cash flow margin	-37,573.5%	Revenue: 65408 Open source Operating Cash Flow: -24356732 Open source Capital Expenditure: 219360 Open source
20242024-12-31	Free cash flow margin	-116.7%	Revenue: 43472000 Open source Operating Cash Flow: -50615000 Open source Capital Expenditure: 116000 Open source
20252025-12-31	Free cash flow margin	55.4%	Revenue: 311709000 Open source Operating Cash Flow: 175046000 Open source Capital Expenditure: 2260000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 175M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	Not reported	No source recorded
20162016-12-31	Operating cash flow	-22265395	Operating Cash Flow: -22265395 Open source
20172017-12-31	Operating cash flow	-28587180	Operating Cash Flow: -28587180 Open source
20182018-12-31	Operating cash flow	-23700565	Operating Cash Flow: -23700565 Open source
20192019-12-31	Operating cash flow	-15052024	Operating Cash Flow: -15052024 Open source
20202020-12-31	Operating cash flow	-21967638	Operating Cash Flow: -21967638 Open source
20212021-12-31	Operating cash flow	-21155223	Operating Cash Flow: -21155223 Open source
20222022-12-31	Operating cash flow	-24356732	Operating Cash Flow: -24356732 Open source
20242024-12-31	Operating cash flow	-50615000	Operating Cash Flow: -50615000 Open source
20252025-12-31	Operating cash flow	175046000	Operating Cash Flow: 175046000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 172.8M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	No source recorded
20162016-12-31	Free cash flow	-22324118	Operating Cash Flow: -22265395 Open source Capital Expenditure: 58723 Open source
20172017-12-31	Free cash flow	-28739168	Operating Cash Flow: -28587180 Open source Capital Expenditure: 151988 Open source
20182018-12-31	Free cash flow	-23749458	Operating Cash Flow: -23700565 Open source Capital Expenditure: 48893 Open source
20192019-12-31	Free cash flow	-15088595	Operating Cash Flow: -15052024 Open source Capital Expenditure: 36571 Open source
20202020-12-31	Free cash flow	-22080276	Operating Cash Flow: -21967638 Open source Capital Expenditure: 112638 Open source
20212021-12-31	Free cash flow	-22580552	Operating Cash Flow: -21155223 Open source Capital Expenditure: 1425329 Open source
20222022-12-31	Free cash flow	-24576092	Operating Cash Flow: -24356732 Open source Capital Expenditure: 219360 Open source
20242024-12-31	Free cash flow	-50731000	Operating Cash Flow: -50615000 Open source Capital Expenditure: 116000 Open source
20252025-12-31	Free cash flow	172786000	Operating Cash Flow: 175046000 Open source Capital Expenditure: 2260000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

50.9% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	8.3%	Total Liabilities: 3090241 Open source Total Assets: 37101729 Open source
20162016-12-31	Liabilities / assets	18.7%	Total Liabilities: 4091860 Open source Total Assets: 21906386 Open source
20172017-12-31	Liabilities / assets	46.5%	Total Liabilities: 6260582 Open source Total Assets: 13453933 Open source
20182018-12-31	Liabilities / assets	73.8%	Total Liabilities: 13891658 Open source Total Assets: 18825914 Open source
20192019-12-31	Liabilities / assets	19.8%	Total Liabilities: 5829650 Open source Total Assets: 29475910 Open source
20202020-12-31	Liabilities / assets	10.3%	Total Liabilities: 5085291 Open source Total Assets: 49308303 Open source
20212021-12-31	Liabilities / assets	8.9%	Total Liabilities: 6147509 Open source Total Assets: 68945576 Open source
20222022-12-31	Liabilities / assets	11.2%	Total Liabilities: 6978523 Open source Total Assets: 62038259 Open source
20242024-12-31	Liabilities / assets	28.8%	Total Liabilities: 34189000 Open source Total Assets: 118846000 Open source
20252025-12-31	Liabilities / assets	50.9%	Total Liabilities: 420835000 Open source Total Assets: 826142000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.11× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	12.11×	Current Assets: 37058863 Open source Current Liabilities: 3061363 Open source
20162016-12-31	Current assets / current liabilities	5.34×	Current Assets: 21831691 Open source Current Liabilities: 4091860 Open source
20172017-12-31	Current assets / current liabilities	2.12×	Current Assets: 13267651 Open source Current Liabilities: 6260582 Open source
20182018-12-31	Current assets / current liabilities	2.4×	Current Assets: 18665054 Open source Current Liabilities: 7766230 Open source
20192019-12-31	Current assets / current liabilities	5.04×	Current Assets: 29349090 Open source Current Liabilities: 5826972 Open source
20202020-12-31	Current assets / current liabilities	11.58×	Current Assets: 48182169 Open source Current Liabilities: 4161583 Open source
20212021-12-31	Current assets / current liabilities	12.44×	Current Assets: 66468829 Open source Current Liabilities: 5345076 Open source
20222022-12-31	Current assets / current liabilities	9.44×	Current Assets: 59551175 Open source Current Liabilities: 6310891 Open source
20242024-12-31	Current assets / current liabilities	3.39×	Current Assets: 114575000 Open source Current Liabilities: 33840000 Open source
20252025-12-31	Current assets / current liabilities	2.11×	Current Assets: 367051000 Open source Current Liabilities: 174269000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 24.64 million Exact value Exact value: -24643627 USD 2016-01-01 – 2016-12-31: -24643627 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2016-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -24643627 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24643627 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495418002777/crmd-20161231.xml#103478 Filing: 000165495418002777 The citation records this snapshot. The page link may show a newer release later.	−USD 22.27 million Exact value Exact value: -22265395 USD 2016-01-01 – 2016-12-31: -22265395 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2016-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -22265395 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22265395 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495418002777/crmd-20161231.xml#117827 Filing: 000165495418002777 The citation records this snapshot. The page link may show a newer release later.	USD 58,723 Exact value Exact value: 58723 USD 2016-01-01 – 2016-12-31: 58723 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2016-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 58723 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 58723 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495418002777/crmd-20161231.xml#118512 Filing: 000165495418002777 The citation records this snapshot. The page link may show a newer release later.	−USD 22.32 million Calculation and evidence -22265395 − 58723 USD Exact free cash flow: -22324118 USD 2016-01-01 – 2016-12-31: -22265395 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 58723 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2016-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -22324118 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22265395 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495418002777/crmd-20161231.xml#117827 Filing: 000165495418002777 Input fundies:CapitalExpenditure: 58723 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495418002777/crmd-20161231.xml#118512 Filing: 000165495418002777 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 33.01 million Exact value Exact value: -33009914 USD 2017-01-01 – 2017-12-31: -33009914 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2017-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -33009914 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33009914 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495419006678/crmd-20181231.xml#132505 Filing: 000165495419006678 The citation records this snapshot. The page link may show a newer release later.	−USD 28.59 million Exact value Exact value: -28587180 USD 2017-01-01 – 2017-12-31: -28587180 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2017-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -28587180 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28587180 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495419006678/crmd-20181231.xml#149612 Filing: 000165495419006678 The citation records this snapshot. The page link may show a newer release later.	USD 151,988 Exact value Exact value: 151988 USD 2017-01-01 – 2017-12-31: 151988 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2017-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 151988 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 151988 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495419006678/crmd-20181231.xml#150323 Filing: 000165495419006678 The citation records this snapshot. The page link may show a newer release later.	−USD 28.74 million Calculation and evidence -28587180 − 151988 USD Exact free cash flow: -28739168 USD 2017-01-01 – 2017-12-31: -28587180 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 151988 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2017-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -28739168 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28587180 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495419006678/crmd-20181231.xml#149612 Filing: 000165495419006678 Input fundies:CapitalExpenditure: 151988 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000165495419006678/crmd-20181231.xml#150323 Filing: 000165495419006678 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 26.83 million Exact value Exact value: -26829630 USD 2018-01-01 – 2018-12-31: -26829630 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2018-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -26829630 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26829630 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390020006521/crmd-20191231.xml#101741 Filing: 000121390020006521 The citation records this snapshot. The page link may show a newer release later.	−USD 23.7 million Exact value Exact value: -23700565 USD 2018-01-01 – 2018-12-31: -23700565 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2018-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -23700565 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23700565 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390020006521/crmd-20191231.xml#245848 Filing: 000121390020006521 The citation records this snapshot. The page link may show a newer release later.	USD 48,893 Exact value Exact value: 48893 USD 2018-01-01 – 2018-12-31: 48893 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2018-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 48893 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48893 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390020006521/crmd-20191231.xml#244783 Filing: 000121390020006521 The citation records this snapshot. The page link may show a newer release later.	−USD 23.75 million Calculation and evidence -23700565 − 48893 USD Exact free cash flow: -23749458 USD 2018-01-01 – 2018-12-31: -23700565 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 48893 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2018-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -23749458 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23700565 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390020006521/crmd-20191231.xml#245848 Filing: 000121390020006521 Input fundies:CapitalExpenditure: 48893 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390020006521/crmd-20191231.xml#244783 Filing: 000121390020006521 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 16.43 million Exact value Exact value: -16433074 USD 2019-01-01 – 2019-12-31: -16433074 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2019-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -16433074 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16433074 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390021018684/f10k2020_cormedixinc.htm#1260810 Filing: 000121390021018684 The citation records this snapshot. The page link may show a newer release later.	−USD 15.05 million Exact value Exact value: -15052024 USD 2019-01-01 – 2019-12-31: -15052024 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2019-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -15052024 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15052024 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390021018684/f10k2020_cormedixinc.htm#1272087 Filing: 000121390021018684 The citation records this snapshot. The page link may show a newer release later.	USD 36,571 Exact value Exact value: 36571 USD 2019-01-01 – 2019-12-31: 36571 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2019-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 36571 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36571 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390021018684/f10k2020_cormedixinc.htm#1275623 Filing: 000121390021018684 The citation records this snapshot. The page link may show a newer release later.	−USD 15.09 million Calculation and evidence -15052024 − 36571 USD Exact free cash flow: -15088595 USD 2019-01-01 – 2019-12-31: -15052024 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 36571 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2019-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -15088595 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15052024 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390021018684/f10k2020_cormedixinc.htm#1272087 Filing: 000121390021018684 Input fundies:CapitalExpenditure: 36571 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390021018684/f10k2020_cormedixinc.htm#1275623 Filing: 000121390021018684 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 22.03 million Exact value Exact value: -22027683 USD 2020-01-01 – 2020-12-31: -22027683 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2020-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -22027683 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22027683 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390022015852/f10k2021_cormedixinc.htm#989375 Filing: 000121390022015852 The citation records this snapshot. The page link may show a newer release later.	−USD 21.97 million Exact value Exact value: -21967638 USD 2020-01-01 – 2020-12-31: -21967638 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2020-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -21967638 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21967638 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390022015852/f10k2021_cormedixinc.htm#1027939 Filing: 000121390022015852 The citation records this snapshot. The page link may show a newer release later.	USD 112,638 Exact value Exact value: 112638 USD 2020-01-01 – 2020-12-31: 112638 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2020-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 112638 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 112638 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390022015852/f10k2021_cormedixinc.htm#1030957 Filing: 000121390022015852 The citation records this snapshot. The page link may show a newer release later.	−USD 22.08 million Calculation and evidence -21967638 − 112638 USD Exact free cash flow: -22080276 USD 2020-01-01 – 2020-12-31: -21967638 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 112638 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2020-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -22080276 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21967638 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390022015852/f10k2021_cormedixinc.htm#1027939 Filing: 000121390022015852 Input fundies:CapitalExpenditure: 112638 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390022015852/f10k2021_cormedixinc.htm#1030957 Filing: 000121390022015852 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 28.21 million Exact value Exact value: -28210226 USD 2021-01-01 – 2021-12-31: -28210226 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2021-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -28210226 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28210226 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390023024310/f10k2022_cormedixinc.htm#1186381 Filing: 000121390023024310 The citation records this snapshot. The page link may show a newer release later.	−USD 21.16 million Exact value Exact value: -21155223 USD 2021-01-01 – 2021-12-31: -21155223 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2021-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -21155223 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21155223 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390023024310/f10k2022_cormedixinc.htm#1195987 Filing: 000121390023024310 The citation records this snapshot. The page link may show a newer release later.	USD 1.43 million Exact value Exact value: 1425329 USD 2021-01-01 – 2021-12-31: 1425329 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2021-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 1425329 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1425329 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390023024310/f10k2022_cormedixinc.htm#1199127 Filing: 000121390023024310 The citation records this snapshot. The page link may show a newer release later.	−USD 22.58 million Calculation and evidence -21155223 − 1425329 USD Exact free cash flow: -22580552 USD 2021-01-01 – 2021-12-31: -21155223 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1425329 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2021-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -22580552 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21155223 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390023024310/f10k2022_cormedixinc.htm#1195987 Filing: 000121390023024310 Input fundies:CapitalExpenditure: 1425329 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390023024310/f10k2022_cormedixinc.htm#1199127 Filing: 000121390023024310 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 29.7 million Exact value Exact value: -29700000 USD 2022-01-01 – 2022-12-31: -29700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2022-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -29700000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29700000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390024021585/ea0201177-10k_cormedix.htm#1241175 Filing: 000121390024021585 The citation records this snapshot. The page link may show a newer release later.	−USD 24.36 million Exact value Exact value: -24356732 USD 2022-01-01 – 2022-12-31: -24356732 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2022-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -24356732 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24356732 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390024021585/ea0201177-10k_cormedix.htm#1185756 Filing: 000121390024021585 The citation records this snapshot. The page link may show a newer release later.	USD 219,360 Exact value Exact value: 219360 USD 2022-01-01 – 2022-12-31: 219360 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2022-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 219360 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 219360 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390024021585/ea0201177-10k_cormedix.htm#1191348 Filing: 000121390024021585 The citation records this snapshot. The page link may show a newer release later.	−USD 24.58 million Calculation and evidence -24356732 − 219360 USD Exact free cash flow: -24576092 USD 2022-01-01 – 2022-12-31: -24356732 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 219360 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2022-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -24576092 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24356732 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390024021585/ea0201177-10k_cormedix.htm#1185756 Filing: 000121390024021585 Input fundies:CapitalExpenditure: 219360 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390024021585/ea0201177-10k_cormedix.htm#1191348 Filing: 000121390024021585 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 46.34 million Exact value Exact value: -46339227 USD 2023-01-01 – 2023-12-31: -46339227 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2023-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -46339227 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46339227 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000101376225001852/ea0234537-10k_cormedix.htm#632313 Filing: 000101376225001852 The citation records this snapshot. The page link may show a newer release later.	−USD 38.41 million Exact value Exact value: -38409480 USD 2023-01-01 – 2023-12-31: -38409480 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2023-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -38409480 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38409480 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000101376225001852/ea0234537-10k_cormedix.htm#642881 Filing: 000101376225001852 The citation records this snapshot. The page link may show a newer release later.	USD 327,300 Exact value Exact value: 327300 USD 2023-01-01 – 2023-12-31: 327300 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2023-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 327300 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 327300 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000101376225001852/ea0234537-10k_cormedix.htm#645990 Filing: 000101376225001852 The citation records this snapshot. The page link may show a newer release later.	−USD 38.74 million Calculation and evidence -38409480 − 327300 USD Exact free cash flow: -38736780 USD 2023-01-01 – 2023-12-31: -38409480 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 327300 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2023-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -38736780 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38409480 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000101376225001852/ea0234537-10k_cormedix.htm#642881 Filing: 000101376225001852 Input fundies:CapitalExpenditure: 327300 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000101376225001852/ea0234537-10k_cormedix.htm#645990 Filing: 000101376225001852 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 17.93 million Exact value Exact value: -17930000 USD 2024-01-01 – 2024-12-31: -17930000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2024-12-31 CORMEDIX INC. (edgar:1410098) Net Income: -17930000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17930000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#935210 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.	−USD 50.62 million Exact value Exact value: -50615000 USD 2024-01-01 – 2024-12-31: -50615000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2024-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: -50615000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50615000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#723888 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.	USD 116,000 Exact value Exact value: 116000 USD 2024-01-01 – 2024-12-31: 116000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2024-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 116000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 116000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#728323 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.	−USD 50.73 million Calculation and evidence -50615000 − 116000 USD Exact free cash flow: -50731000 USD 2024-01-01 – 2024-12-31: -50615000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 116000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2024-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: -50731000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -50615000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#723888 Filing: 000121390026023889 Input fundies:CapitalExpenditure: 116000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#728323 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 163.06 million Exact value Exact value: 163055000 USD 2025-01-01 – 2025-12-31: 163055000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Net Income: 163055000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 163055000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#1360520 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.	USD 175.05 million Exact value Exact value: 175046000 USD 2025-01-01 – 2025-12-31: 175046000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Operating Cash Flow: 175046000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 175046000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#723435 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.	USD 2.26 million Exact value Exact value: 2260000 USD 2025-01-01 – 2025-12-31: 2260000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Capital Expenditure: 2260000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2260000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#727877 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.	USD 172.79 million Calculation and evidence 175046000 − 2260000 USD Exact free cash flow: 172786000 USD 2025-01-01 – 2025-12-31: 175046000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 2260000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORMEDIX INC. · 2025-12-31 CORMEDIX INC. (edgar:1410098) Free cash flow: 172786000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:29:40Z Snapshot: b54bb3d03fac1212784a0e217173e60c14c9aba106282a45f10ab288bf72f307 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1410098?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 175046000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#723435 Filing: 000121390026023889 Input fundies:CapitalExpenditure: 2260000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm#727877 Filing: 000121390026023889 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

173 filings · 4,775 latest values · 4,775 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001410098, 1410098, CRMD, edgar:1410098

Also known as CORMEDIX INC., CorMedix Inc.

CORMEDIX INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation